De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling

Ingrid E Wertz1, Karen M O'Rourke, Honglin Zhou

  • 1Department of Molecular Oncology, School of Medicine, University of California, Davis, Davis, California 95616, USA.

Nature
|July 20, 2004
PubMed

Insights

A20 protein inhibits chronic inflammation by removing and adding ubiquitin chains to RIP, a key signaling molecule. This dual action targets RIP for degradation, downregulating NF-kappaB signaling and preventing cell death.

Area of Science:

  • Molecular Biology
  • Immunology
  • Biochemistry

Background:

  • NF-kappaB transcription factors are crucial mediators of pro-inflammatory cytokines, including tumor necrosis factor-alpha and interleukin-1beta.
  • Dysregulated NF-kappaB activity leads to chronic inflammation and cell death, as evidenced in A20-deficient mice.
  • A20 is recognized as a potent inhibitor of NF-kappaB signaling, yet its precise mechanism of action remained elusive.

Purpose of the Study:

  • To elucidate the mechanism by which A20 downregulates NF-kappaB signaling.
  • To characterize the distinct roles of A20's ubiquitin-editing domains in regulating inflammatory pathways.
  • To identify novel ubiquitin ligase domains and sequential regulatory mechanisms.

Main Methods:

  • Investigated the enzymatic activities of A20's N-terminal de-ubiquitinating (DUB) and C-terminal ubiquitin ligase domains.
  • Analyzed the ubiquitination status of receptor interacting protein (RIP) in response to TNF receptor 1 (TNFR1) signaling.
  • Utilized proteasomal degradation assays to assess the fate of RIP.

Main Results:

  • A20's N-terminal OTU domain removes K63-linked ubiquitin chains from RIP.
  • A20's C-terminal zinc finger domain polyubiquitinates RIP with K48-linked chains, targeting it for proteasomal degradation.
  • Demonstrated a novel mechanism of NF-kappaB downregulation through sequential ubiquitin editing of RIP.

Conclusions:

  • A20 employs a dual ubiquitin-editing strategy involving de-ubiquitination and subsequent polyubiquitination of RIP.
  • This coordinated action effectively terminates NF-kappaB signaling, preventing chronic inflammation.
  • Highlighted A20 as a key example of a protein with distinct DUB and ubiquitin ligase domains mediating specific regulatory functions.

Related Concept Videos

Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...